Commercialization: Page 29
-
PharmaVoice Team/PharmaVoice
"I Want My Brand on Social!"
Social media is ubiquitous. Everyone is on it in some capacity. We are all hands-on experts; but social is very nuanced. How do I leverage creative, messaging, audience, device, time of day, etc., to connect with my customers? A successful start requires focus on a strategy—one that is as individ...
By Joe Youssef • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Transcending Traditional Social Media: From Awareness to Uncovering Actionable Insights
It goes without saying that social media is one of the most widely used forms of communication today. Pharmaceutical companies are trying to “crack the code" and understand how to effectively use this channel to achieve organizational initiatives while complying with rigorous industry regulations...
By Dr. Theodore Search • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Industry Gears Up For Track and Trace
Counterfeit medicines have taken a huge toll, both in terms of human costs as well as financially. Interpol estimates that 1 million deaths each year can be linked to counterfeits. According to PwC, counterfeit pharmaceuticals are a $200 billion-plus annual business. The problem is most severe in...
By Kim Ribbink • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Red Zone: Applying User Experience Design to Develop Effective Patient Suport
Treatment nonadherence is a complex behavior that requires much more than a simple one-size-fits-all approach to address the challenge. What can pharma learn from the behavioral sciences to deliver patient support that is effective in improving tx adherence? Health psychology and behavioral econo...
By Kate Perry • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Warp Speed Ahead It’s that time of year again — time to pause, reflect, and take stock of the year that was, while gearing up for the wild ride that lies ahead. This time last year, we had just elected a new president, and today there remains quite a bit of uncertainty as to what President Trump...
By Taren Grom • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Upfront
Pfizer Service Provides Social Workers for Patients Pfizer Oncology Together is a first-of-its-kind offering for patients taking Pfizer Oncology medicines. The program offers dedicated social workers called “Care Champions" to help navigate the complexities that accompany treatment, such as ident...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
HealthTech
LivaNova Receives FDA Approvals for SenTiva Device for Treatment of Epilepsy Trend Watch: Health Technology Increases Wellness Across Epilepsy, Autism, and Weight Loss LivaNova, a market-leading medical technology company, has received FDA approval for its latest vagus nerve stimulation therapy (...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Last Word
Digital Health Initiatives Georgia Mitsi, Senior Director, Search Evaluation & Digital Health Care Initiatives, at Sunovion Pharmaceuticals, discusses the company’s digital health efforts. PV: What is the driving force behind the many digital health initiatives at Sunovion? Mitsi: Sunovion’s ...
By Georgia Mitsi • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: What Does the Future Hold?
We tasked the PharmaVOICE 100 community of industry executives to think about some of the most important trends they expect will challenge the status quo, move the industry forward, and contribute to breakthroughs in medicine and business models. Their thoughtful insights signal the multitude of ...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Agile Marketing
Agile methodology is all about leveraging experiences and failures to improve a process, and has been adopted across industries and entities to organize everything from software development to household chores and family activities. Rooted in IT, the agile manifesto has been adopted by winemakers...
By Robin Robinson • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Alternative Delivery
Point and click — could ordering your prescription drugs be as easy as that? Some experts say yes, some say we’ll see. But there is one thing for sure: the retail pharmacy world is changing. And one disrupter — Amazon — is in the middle of it all. And with Amazon’s mass distribution system, the e...
By Taren Grom • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Artificial Intelligence
Artificial intelligence (AI) in health represents a collection of multiple technologies, enabling machines to sense, comprehend, act, and learn so they can perform administrative and clinical healthcare functions. There are different applications of AI and machine learning in pharma, including di...
By Taren Grom • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Bioethics
New technologies for gene editing have created excitement about the potential for cures for diseases, as well as debates around ethics and regulatory oversight that are sure to dominate this field of science for years to come. CRISPR-Cas9, the newest gene-editing tool, is getting a lot of attenti...
By Denise Myshko • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Brand Engagement
As patients start to manage their health through digital devices, not only does the pharma industry need to be more patient-centric, but the brand story must focus on the patient and his or her journey to create true brand engagement. According to a report from DRG Digital, as the pharmaceutical ...
By Robin Robinson • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Pipeline Disrupters
In recent years, several therapeutic disruptors have hit the market, pushing aside current standard treatment protocols. From hepatitis C cures to immuno-oncology therapies, recent approvals have upended how diseases are treated, providing patients with significant advances. Pharmaceutical, biote...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Rare Diseases
In recent years, a growing number of companies have entered the rare disease space, bolstered by regulatory incentives, such as the Orphan Drug Act, and scientific breakthroughs. While each rare disease has a relatively small patient population — defined in the United States as affecting fewer th...
By Kim Ribbink • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Real-World Outcomes
Real-word outcomes is not a new trend by any means, but it’s a market-changing model that is coming into its own and worthy of covering. That’s because the pharmaceutical market continues to shift to an outcomes-based reimbursement system, driven by payers’ need to rein in rising drug prices, adv...
By Denise Myshko • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Treatment to Wellness
Attitudes about treating disease are undergoing a fundamental shift as the life-sciences industry faces pressure to demonstrate value. Increasingly, there is a move from treatment to prevention, diagnostics and cure, which KPMG says is leading to the rise of new competitors. By 2030, practitioner...
By Kim Ribbink • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: eSolutions: Digital Takes Center Stage
Recent trends suggest that pharma companies will continue to invest in digital solutions and partner with innovative technology companies to inform business and clinical decision-making. Yet according to McKinsey, many pharma executives find it hard to determine which digital initiatives to scale...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Picture This: Managing the Entire Lifecycle of Clinical Trial Images in a Single Tool
One of the great promises of technology is that it can simplify our lives. The need for it to do so is particularly strong in clinical research, where trials have been growing ever more complex. This is due, in part, to regulators’ increasing requests for the inclusion of imaging analysis when ev...
By Tim Kulbago • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Digital Solutions That Make Sense to Support Sales Team Initiatives
Personal detailing by pharmaceutical sales representatives to physicians and other healthcare professionals has traditionally been the foremost effective way of brand marketing. Reportedly, pharmaceutical companies’ per capita spend on personal detailing visits exceeds direct-to-consumer marketin...
By Brandie Lifante • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Red Zone: Healing Patients With Digital Warmth: A Prescription for Life Sciences
Earlier this year, ReD Associates and Cognizant conducted an extensive research that cut across disease areas to understand how patients heal – that is, what happens when people face a health risk or issue and need to manage or overcome it. By participating in people’s everyday lives, we found th...
By Bhaskar Sambasivan • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Red Zone: safety portal: Increasing Patient Safety While Reducing Cost and Complexity
Although it sounds straightforward, global safety reporting of clinical trial adverse events is complicated, time-consuming and extremely expensive. Despite the substantial investment of time and money, research shows that global safety reporting is not protecting patients as well as it could. Dr...
By Steven Beales • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Red Zone: Leveraging Behavioral Economics to Guide Healthy Decision-Making
People living with long-term health conditions make many decisions about their health, often on a daily basis, including whether to adhere to prescribed treatments. What insights from the world of psychology can help us create effective programs that guide healthy decision-making around adherence...
By Kate Perry • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
The Launch Pad Preparing for Product Launch
Launching a pharmaceutical product has never been easy, but in years past it was certainly simpler. The days of focusing singularly on high-decile prescribing docs and sending out an army of sales reps are a distant memory. Today’s marketers must establish a value story for physicians, patients, ...
By Robin Robinson • Oct. 1, 2017
Previous
